You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
Promising long-term data boosts Abera's nasal flu vaccine
Text:
Tommie Anderberg | [email protected]
Abera Bioscience has presented promising new long-term preclinical data for its nasal influenza vaccine – a future alternative to traditional injected influenza vaccines. The results show strong and persistent immune responses in both mucosal and...